Evidence map›Paper›PMID 37560472›Full record

ArticleFrontiers in pharmacology2023

Enrichment analysis of phenotypic data for drug repurposing in rare diseases.

Alberto Ambesi-Impiombato, Kimberly Cox, Sylvie Ramboz, Daniela Brunner, Mukesh Bansal, Emer Leahy

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases.Advances in pharmacological and pharmaceutical sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alberto Ambesi-ImpiombatoPsychoGenics, Paramus, NJ, United States.
Kimberly CoxPsychoGenics, Paramus, NJ, United States.
Sylvie RambozPsychoGenics, Paramus, NJ, United States.
Daniela BrunnerPsychoGenics, Paramus, NJ, United States.
Mukesh BansalPsychoGenics, Paramus, NJ, United States.
Emer LeahyPsychoGenics, Paramus, NJ, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced Behavioral Signature Analysis (DBSA), is a machine learning (ML) method for

Indexed as

animal modelscomputational methoddrug discoveryhuntington (disease)phenotypic screeningsmartcubetianeptine

Identifiers

PMID37560472
PMCPMC10407094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.